• Home
  • Blog

Call us today! +1 (352) 353-0052

Find our Location
info@derivatixcapital.com
Login

Login
Derivatix Capital ManagementDerivatix Capital Management
  • Home
  • Blog

Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022

Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022

Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022

April 19, 2022 Uncategorized

Happy spring to all who have been waiting long for outdoor activities….

2022-Q1 Market Summary*:

U.S. equities closed out their first quarterly loss in two years due initially to soaring inflation and the Fed’s hawkish pivot. Economic measures of inflation had already reached 40-year highs in the previous quarter, with the November CPI registering +6.8%, before climbing higher in consecutive months to the most recent reading of +7.9% in February.

With global economies still adjusting to Covid’s impact on supply chains and the shift in consumer spending, Russia’s invasion of Ukraine at the end of February was the equivalent of adding fuel to the inflation fire. Commodity and rates accelerated higher from existing uptrends as the West imposed strict sanctions on Russia’s economy and central bank. Ironically, most U.S. equity benchmarks bottomed within a day of the Russian invasion.

Derivatix Performance:

S&P 500 and NASDAQ had a very volatile 2022 Q1 and dropped as low as 14% and 20% before ending the quarter at about 5% and 9% loss respectively. At the same time, Derivatix encounters a small decline of only 2.74% for the quarter. This moderate change compared to the large fluctuations in the market could only be occurred by utilizing proper risk management and protection in place inside the fund which will be practiced for the rest of the year for any other potential market volatility.

Source *:NASDAQ

Share
2

You also might be interested in

Derivatix Quarterly Report: Mid 2020-Q1 as of Feb. 29th, 2020

Derivatix Quarterly Report: Mid 2020-Q1 as of Feb. 29th, 2020

Mar 6, 2020

While the world is fighting against the coronavirus pandemic, don’t[...]

RESULT & STANDING (MONTH 07) – AS OF MAR. 31, 2016

Mar 31, 2016

Happy Spring everyone!  I know some of you who still[...]

RESULT & STANDING (MONTH 01) – AS OF SEP. 30, 2015

Sep 30, 2015

​Derivatix First Options Fund finished September 2015 with more than[...]

Recent Posts

  • Derivatix Quarterly Report: 2023-Q1 as of Mar. 31, 2023
  • Fundamentals of Options Seminar, Mar. 10, 2023
  • Derivatix Quarterly Report: 2022-Q4 as of Dec. 31, 2022
  • Derivatix Quarterly Report: 2022-Q2 as of Sep. 30th, 2022
  • Derivatix Quarterly Report: 2022-Q2 as of Jun. 30th, 2022
  • Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022
  • Derivatix Quarterly Report: 2021-Q4 as of Dec. 31st, 2021
  • Derivatix Quarterly Report: 2021-Q2 as of Sep. 30th, 2021

Recent Comments

    Archives

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Recent Comments

    Find us on

    Contact Us

    We're not around right now. But you can send us an email and we'll get back to you, asap.

    Send Message

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.

    Contact Info

    • Derivatix Capital Management
    • +1 (352) 353-0052
    • info@derivatixcapital.com
    • derivatixcapital.com

    Fresh from blog

    • Derivatix Quarterly Report: 2023-Q1 as of Mar. 31, 2023
    • Fundamentals of Options Seminar, Mar. 10, 2023
    • Derivatix Quarterly Report: 2022-Q4 as of Dec. 31, 2022
    • Derivatix Quarterly Report: 2022-Q2 as of Sep. 30th, 2022
    • Derivatix Quarterly Report: 2022-Q2 as of Jun. 30th, 2022
    • Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022

    © 2023 — Derivatix Capital Management.

    • Home
    • Blog
    Prev Next

    Accredited Investors Only

    The information contained on this website is intended solely for informative purposes and does not represent a solicitation.

    By continuing to browse this site, you agree and confirm that you are an Accredited Investor.